was suggested by the observation that the frequency distribution of this number in the normal population was not unimodal (10, 14) ; rather, two groups of individuals were found to have numbers of CR1 in the high and intermediate range of the population, respectively, with a third, less distinct group having numbers in the lower range. It was proposed that this distribution reflected polymorphism of a regulatory element having at least two autosomal codominant alleles. Additional evidence for the existence of such a regulatory element has now been obtained by the identification of a CR1 genomic polymorphism that correlates with the level of CR1 expression on E.
Materials and Methods
Antibodies. Rabbit IgG anti-CR1 was prepared as described previously (3) . The murine monoclonal IgG1 anti-CRl YZ-I (15) was purified from ascites by precipitation with 50% saturated ammonium sulfate and chromatography on DEAE Sephacel (Pharmacia Fine Chemicals, Piscataway, N J), and portions were radiolabeled with ~z~I (Amersham Corp., Arlington Heights, IL) to sp act of 0.8-1.4 X 106 cpm/#g (16) . Fab fragments of the purified YZ-1 were produced by papain digestion (17) and were radiolabeled to asp act of 1.4 x 10 ~ cpm/ug. Murine IgG1 from the tumor line MOPC 21, which has no known antigen-binding activity (Litton Bionetics, Kensington, MD); biotin-conjugated monoclonal anti-B1 (Bl-biotin; ~ Coulter Electronics Inc., Hialeah, FL), which recognizes a 35,000 M, antigen present on the surface of B lymphocytes (18) , and FITC-conjugated goat IgG anti-mouse IgG (FITC-GaM) (Southern Biotechnology Associates, Birmingham, AL) were purchased.
Enumeration of CR1 of Erythrocytes, Neutrophils, and B Lymphocytes. The number of CR1 on erythrocytes was determined by incubation of washed erythrocytes for 1 h at 22°C with 1 ~g/m1125I-YZ-I in the absence or presence of excess, unlabeled YZ-1 followed by centrifugation of the erythrocytes through cushions of dibutylphthalate (Eastman Kodak Co., Rochester, NY) (10) . Total cellular CR1 of purified neutrophils (19) was measured by a modification of the sandwich protocol of Unkeless and Healy (20, 21) in which the detergent-soluble fraction of lysates of neutrophils was incubated with 1.25 tlg/ml J25I-YZ-1 Fab, and the CR1J2~I-Fab complexes were immunoprecipitated by Staphylococcus aureus particles (Bethesda Research Laboratories, Gaithersburg, MD) charged with polyclonal rabbit lgG anti-CR1. CRI on B lymphocytes was quantified by two-color immunofluorescent flow cytometry (12) ; B ceils were identified by staining with Bl-biotin and rbodamine 600 (XRITC)-conjugated avidin (Vector Laboratories, Inc., Burlingame, CA), and the amount of CR 1 on the cells was measured by staining with YZ-1 and FITC-GaM. Immunofluorescent staining was analyzed with a Cytofluorograf System 50-H (Ortho Diagnostic Systems Inc., Westwood, MA) ec]uipped with an argon laser operated at 488 nm and 250 mW and a krypton laser operated at 568.2 nm and 200 roW, and interfaced with a model 2150 Data Handler (Ortho Diagnostic Systems Inc.).
Analysis of CR1 by PAGE. CRI in detergent lysates oferythrocytes or neutrophils that had been surface-labeled with ~2.~! (16) was immunoprecipitated as described (7) using YZ-1 IgG that had been coupled to CNBr-activated-Sepharose (Sigma Chemical Co., St. Louis, M O). The immunoprecipitated CR 1 was eluted by incubation for 3 min at 100°C in 1% SDS and was analyzed after reduction and alkylation by SDS-PAGE (22) on slab gels containing a gradient of 3-10% acrylamide, followed by autoradiography.
Southern Blot Analysis of Genomic DNA. Genomic DNA was isolated from peripheral blood leukocytes (23) and analyzed by Southern blot hybridization (24) using the 0.75-kb CRI cDNA probe, CRI-I, which represents a portion ofa 1.2-kb sequence that occurs in at least two highly homologous copies in the coding sequence of the CR 1 gene (25, 26) .
Abbreviations used in this paper: Bl-biotin, biotin-conjugated monoclonal anti B-I; FITC-GaM, FITC-conjugated goat lgG anti-mouse IgG; RFLP, restriction fragment length polymorphism; XRITC, rhodamine 600. 
Results
Leukocyte DNA was prepared from healthy individuals having numbers of CR1 on their E in the high (708-1,114 CR1 sites per cell), intermediate (478-570 sites per cell), and low (174-208 sites per cell) ranges, respectively. The DNA was digested with a panel of restriction enzymes and Southern blots were hybridized with the 0.75-kb CR1 cDNA probe, CRI-1. This probe hybridizes under" stringent conditions not only to its complementary sequence but also to other highly homologous sequences that occur within the coding sequence of the CR 1 gene (25, 26) . The existence of these repeating sequences accounts, at least in part, for the multiple genomic restriction fragments to which the probe hybridizes. Using Hind III, we observed a restriction fragment length polymorphism (RFLP) involving fragments of 7.4 kb and 6.9 kb that appeared to correlate with the variations in the quantitative expression of CR1 (Fig. 1 ). All four individuals having high CR 1 sites/E had only the 7.4-kb fragment, three of the four persons having low CR1 had only the 6.9-kb fragment, and three of the four individuals having intermediate numbers of CRI had both fi-agments. Therefore, a larger" group of normal individuals was analyzed for CR 1 number on E and for the occurrence of these Hind III restriction fragments. All 50 individuals had either the 6.9-kb fragment, the 7.4-kb fragment, or both (Fig.  2) . The number of CR1 sites on E from persons having only the 7.4-kb restriction fragment was 611 + 33 (mean + SEM). Although there was considerable overlap, the 11 donors having both restriction fragments had significantly fewer sites per E, 455 + 52 (p < 0.005). Individuals having only the 6.9-kb fragment showed less variation in CR1 expression than did the other two groups, not overlapping with any person hontozygous for the 7.4-kb fragment, and had a mean of only 156 + 13 sites per E (significance of the difference of means for either higher group, p < 0.001).
The probe with which the Hind III RFLP was detected, CRI-1, shows in situ hybridization to a single chromosomal locus, lq32 (26) . The linkage of this RFLP to the structural gene for CR1 was confirmed by examining in an informative family whether the Hind III restriction fragments cosegregated with the S, F, and F' structural allotypes of CR1 (Fig. 3A) . In individuals II-1, II-2, III-l, and III-2, gels of 125I-labeled CR1 from both E (Fig. 3A) and neutrophils ( Fig. 3B) were obtained to aid in the definitive assignment of CR1 structural allotypes. The individual designated I-2 was heterozygous for the F and F' structural allotypes and homozygous for the 7.4-kb Hind III fragment. Every descendant of I-2 who inherited the F' allotype (II-1, II-2, III-1, and III-2) also had the 7.4-kb Hind II! fragment. The F allotype of individual II-1 was necessarily inherited from his father, individual I-I, and this allotype cosegregated with the 6.9-kb Hind III fragment in all cases, including individuals II-1, II-2, and III-3. Finally, the S and F allotypes of individual II-3 cosegregated with the 7.4-and 6.9-kb Hind III fragments, respectively, in individuals III-1, III-2, and III-3. Thus, the element identified by the Hind III RFLP that regulates the quantitative expression of CR1 is linked to the CR1 gene.
Previous studies have indicated that the relative proportions of the CR1 structural allotypes expressed on E of different heterozygous individuals were relatively constant over time (6, 7) , and have suggested that these ratios might be genetically controlled (8, 9, Rodriguez de Cordoba, personal communication, New York Blood Center, New York). Having shown that the Hind III RFLP FmURE 3. Segregation in a normal family of Hind 111 RFLP, structural allotype of CR1 and C R 1/E. N umber of CR 1/E is shown inside each symbol. An autoradiogram of the SDS-PAGE of CR1 protein immunoprecipitated from each individual's surface-l~51-1abeled E is shown beneath each figure, and the positions of the S, F, and F' allotypes of CR1 and the 200-kD molecular mass marker are indicated. The 7.4-kb and 6.9-kb Hind III fragments that were seen in Southern blots of each individual's DNA are shown adjacent to the allotypic form of CR 1 with which they cosegregated. An autoradiogram of the SDS-PAGE of CR 1 immunoprecipitated from surface-l-labeled neutrophils of individuals II-1, II-2, III-1, and 111-2 is shown in the inset. a n d the locus d e f i n i n g the C R 1 s t r u c t u r a l allotypes a r e linked, it was possible to assess w h e t h e r the r e g u l a t o r y e l e m e n t associated with this R F L P was cis-o r transa c t i n g by c o m p a r i n g the relative a m o u n t s o f the S, F, a n d F ' allotypes e x p r e s s e d on E o f the i n d i v i d u a l s d e p i c t e d in Fig. 3 . T h e F ' a l l o t y p e that is associated with the 7.4-kb H i n d III f r a g m e n t in individuals I-2, II-1, II-2, III-1, a n d III-2 is e x p r e s s e d in large quantities on E o f each o f these individuals. In contrast, the 6.9-kb f r a g m e n t -a s s o c i a t e d F a l l o t y p e o f individuals I -l , II-1, II-2, a n d III-3 is e x p r e s s e d in relatively small quantities. T h u s , the r e g u l a t o r y e l e m e n t that is linked to these 7.4-kb and 6.9-kb Hind III restriction fragments cis-regulates CR1 expression by E. The expression of the S allotype of individual II-3 that was associated with the 7.4-kb fragment did not exceed that of his 6.9-kb fragment-associated F allotype. Moreover, the expression of this S allotype on E of individuals III-1 and III-3 was relatively low, and the three individuals having this allele had only 202, 326, and 192 CR1 sites per E, respectively. Therefore, in these individuals the factors causing low CR 1 number in association with the 7.4-kb allele also were inherited and were expressed in a cis-acting manner.
Visual comparison of the proportions of the structural allotypes of CR1 expressed on E (Fig. 3A) and neutrophils (Fig. 3B ) of individuals II-1, II-2, III-1, and III-2 of Fig. 3 suggested that factors regulating the amounts of CR1 on these two cell types may differ, in accord with earlier findings (7, 9, 27) . To investigate further whether such regulation might be cell-type-specific, eight normal individuals were selected, four homozygous for the 7.4-kb Hind III fragment and four homozygous for the 6.9-kb fragment, and CR1 was quantified on their E by the binding of 125I-YZ-1, on their B cells by two-color immunofluorescent flow cytometry, and in their neutrophils by a sandwich RIA of total cellular CR1 (Fig. 4) . For B cells and neutrophils, determinations for all eight individuals were performed simultaneously to avoid interassay variation. The mean number of CR1/E for the individuals homozygous for the 7.4-kb Hind III fragment was 886 -+ 94, significantly higher than that for the individuals homozygous for the 6.9-kb fragment, 159 _+ 18 (p < 0.001). When the amount of CR1 present on B cells, identified by their red fluorescent staining by B1-biotin and XRITC-avidin, was expressed as the relative intensity of green fluorescent staining by YZ-1 and FITC-GaM, B cells of the individuals who were homozygous for the 7.4-kb fragment had a mean relative fluorescence for CR 1 of 26.7 + 2 (SEM), not significantly different from that of B cells from individuals who were homozygous for the 6.9-kb fragment, 29.1 _+ 6 (p > 0.2). The individuals homozygous for the 7.4-kb fragment and those homozygous for the 6.9-kb fragment also were similar in the total amount of CR1 in their neutrophils, 43,870 + 4,010 and 42,985 +_ 2,184 CR1/cell, respectively (p > 0.8). Thus, regulation of total CR1 expression by the element associated with the Hind III RFLP is apparent only in erythrocytes.
Discussion
In Southern blots of genomic DNA that had been digested with Hind III, the 0.75-kb probe, CRI-1, hybridized to multiple fragments having an aggregate length of ~80 kb (Fig. 1) . This circumstance permitted analysis of a large portion of the CR 1 gene with a probe that was derived from < 10% of the CR 1 transcript (25) . Among 50 healthy donors (Fig. 2) , a polymorphism involving two restriction fragments of 6.9 kb and 7.4 kb was found to correlate with the level of CR1 expression on E. The occurrence in all individuals of either or both restriction fragments is consistent with their being allelic, and family studies supported this possibility (Fig. 3) . The additional finding that a corresponding polymorphism was not observed with the enzymes Eco RI, Bam HI, and Pvu II (data not shown) suggests either that the two alleles differ at only a few nucleotides or that there are cleavage sites for these three enzymes between the polymorphic region and the hybridization site for CR 1-1. Presumed homozygosity for the form of the regulatory element identified by the 6.9-kb and by the 7.4-kb restriction fragment was associated with low and high numbers of CR 1 on E, respectively, whereas heterozygosity was associated with CR1 number on E in the intermediate range (Fig. 2 ). This regulatory element was shown to be linked to the CR1 structural gene and cis-acting by showing that it regulated the relative amounts of the S, F, and F' structural allotypes of CR 1 expressed on E in three generations of a family (Fig. 3) . Studies of CR1 expression by ]eukocytes suggested that the effects of this regulatory element were tissue-specific (Figs. 3 and 4) . However, unequal expression of the CR 1 structural allotypes that paralleled that on E was also observed on neutrophils of individual III-2 of Fig. 3 .
Inherited differences in the expression of CR1 could result from structural alterations affecting its membrane insertion or stability. For example, inherited changes in the transmembrane and cytoplasmic domains of low density lipoprotein receptors resulted in the secretion of most of these receptors from fibroblasts (28) . Although CR1 of E from individuals homozygous for either of the two forms of the Hind III RFLP did not differ on SDS-PAGE and there was no corresponding alteration in CR 1 expression by their leuokocytes, possible differences in protein structure of their CR1 can be excluded only by comparing the coding sequences of the CR1 genes associated with the 6.9-kb and 7.4-kb restriction fragments. Altered stability of CR1 resulting from differences in primary structure of the receptor might be more apparent on erythrocytes than leukocytes because of the longer life span of the former cell type and its lack of biosynthetic capacity.
Observed differences in CR1 expression also could be caused by factors affecting protein synthesis, including differential transcription initiation, RNA splicing, polyadenylation, rates of mRNA processing and transport, stability of the message in the cytoplasm, or rates of translation or intracellular degradation. In eukaryotic genes the steady state levels of message appear to be regulated primarily by modulation of transcription initiation (29) , as has been found for the genes encoding Ig light and heavy chains (30) (31) (32) (33) , insulin (34) , and chymotrypsin (34) . Thus, the Hind lII RFLP might identify allelic forms of either promoter or enhancer elements, both of which are cis-acting, and the tissuespecific nature of the CR1 regulatory element may favor the possibility that it is an enhancer. The threefold span of CR1 number on E of individuals who are homozygous for the 7.4-kb Hind III fragment indicates either that a recombination event has occurred between the regulatory element and the Hind III restriction sites, or that additional genetic factors influencing CR1 expression are superimposed on the regulatory element identified in this study. However, the regulatory element associated with the 6.9-kb Hind III fragment, when present in the homozygous state, overrides the effects of such additional genetic factors (Fig. 2) . Summary A genetic basis for the regulation of the number of CR1 on E of different normal individuals was investigated by probing Southern blots of their genomic DNA with a 0.75-kb fragment of CR1 cDNA. Using Hind III, we observed a RFLP involving fragments of 7.4 kb and 6.9 kb that correlated with the number of CR1 on E. 32 individuals baying only the 7.4-kb restriction fragment had a mean of 661 + 33 (SEM) CR1/E, 11 donors having both restriction fragments had a mean of 455 + 52 CR1/E, and 7 individuals having only the 6.9-kb fi'agment had a mean of 1.56 + 13 CR1/E, all means being significantly different (p < 0.005). Cosegregation in a normal family of the Hind III restriction fragments with the S, F, and F' structural allotypes of CR1 confirmed that the regulatory element identified by these fragments is linked to the CR1 gene. Moreover, an analysis of the relative expression on E of these structural allotypes in association with either the 7.4-kb Hind III fragment or the 6.9-kb fragment showed that this regulatory element is cis-acting. In contrast, quantitation of CR1 of B lymphocytes and neutrophils revealed no differences in total CR1 expression between individuals homozygous for the 7.4-kb and 6.9-kb Hind III fragments. Thus, we have identified a genomic polymorphism that is linked to the CR1 gene and is associated with a cis-acting regulatory element for the expression of CR1 on E.
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